Shikimate-Derived Meroterpenoids from the Ascidian-Derived Fungus SYSU-MS7908 and Their Anti-Glioma Activity.

Glioma is a clinically heterogeneous type of brain tumor with a poor prognosis. Current treatment approaches have limited effectiveness in treating glioma, highlighting the need for novel drugs. One approach is to explore marine natural products for their therapeutic potential. In this study, we isolated nine shikimate-derived diisoprenyl-cyclohexene/ane-type meroterpenoids (-), including four new ones, amphicordins A-D (-) from the ascidian-derived fungus SYSU-MS7908, and further semisynthesized four derivatives (-). Their structures were extensively characterized using 1D and 2D NMR, modified Mosher's method, HR-ESIMS, NMR and ECD calculations, and X-ray crystallography. Notably, amphicordin C () possesses a unique benzo[]chromene (6/6/6) skeleton in this meroterpenoid family. In an anti-glioma assay, oxirapentyn A () effectively inhibited the proliferation, migration, and invasion of glioma cells and induced their apoptosis. Furthermore, an analysis suggested that oxirapentyn A has the potential to penetrate the blood-brain barrier. These findings highlight the potential of oxirapentyn A as a candidate for the development of novel anti-glioma drugs.